← Browse by Condition
Medical Condition

primary sj gren s syndrome

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06979531 Phase 2
Recruiting

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

Enrollment
180 pts
Location
United States, Argen...
Sponsor
Immunovant Sciences GmbH
View Trial →